Lung transplantation is a life-saving treatment for patients with end stage lung disease. The
imbalance between lung graft supply and recipients has been a serious issue and barrier to …

This review outlines the new and promising technique of ex vivo lung perfusion and its
clinical potential to increase the number of transplantable lungs and to improve the early …

Background: Many patients awaiting lung transplantation die before a donor organ becomes
available. Ex vivo lung perfusion (EVLP) allows initially unusable donor lungs to be …

Background Ex vivo lung perfusion (EVLP) was primarily developed for evaluation of
impaired donor lungs. The good clinical results raise the question for its possible impact on …

Primary graft dysfunction: lessons learned about the first 7... : Current Opinion in Organ
Transplantation Primary graft dysfunction: lessons learned about the first 72 h after lung …

Background Ex vivo lung perfusion (EVLP) is an effective method to assess and improve the
function of otherwise unacceptable lungs, alleviating the shortage of donor lungs. The early …

Dysfunction of the pulmonary allograft with impaired oxygenation and radiographic opacities
consistent with pulmonary edema occurs in up to 50% of lung transplant (LTx) recipients. 1 …

Lung transplantation (LTx) is an established treatment option for eligible patients with end-
stage lung disease. Nevertheless, the imbalance between suitable donor lungs available …

Objective Ex vivo lung perfusion (EVLP) is reportedly a useful strategy that permits marginal
donor lungs to be evaluated and reconditioned for successful lung transplantation (LTx) …

The term primary graft dysfunction (PGD) incorporates a continuum of disease severity from
moderate to severe acute lung injury (ALI) within 72 h of lung transplantation. It represents …